4 Small-Caps On The Rise - WTP, MGV, ANP and POW

Even after the negative sentiments driven from the west the Australian stock exchange closed the day 1.1 percent up while the small ordinaries were still struggling, and the index was down 0.15 percent to 2,541 at mid-day. Some of the small-cap stocks, however, turned it around and witnessed a positive change.

WATPAC (ASX:WTP) – The stock is trading at a 52-week high which shot up 41.221% up at $ 0.925 as at October 29, 2018. As BESIX is now proposing to acquire 100% of the Watpac Shares it does not already own by way of an unconditional all-cash off-market takeover bid for the same consideration as was offered under the Scheme. An independent expert rated the offer as reasonable and fair after valuing the stock between 81c to 95c per share. The earnings per share (EPS) of the company is at -0.309 AUD and reflects restricted profits. The market capitalization of $120.12 million keeps the company in small cap segment. However, the stock has witnessed a performance change of -9.03% over the past 12 months. Â

MUSGRAVE MINERALS LIMITED (ASX:MGV) – After reporting more high-grade gold discoveries at its flagship project in Western Australia, the company made big gains this morning of October 29, 2018. A 37 percent increase on Friday’s close, the stock hit an intraday high of 8.1c. Close to the dawn gold deposit at the Cue project the drilling results came from Musgrave’s Lake Austin North prospect which is proving to be a large, well-mineralized system and to further outline the size and grade of this new and exciting gold discovery the current diamond drilling program will be aimed. The market capitalization of the company is $19.29 million which keeps Musgrave in small cap segment. The stock has witnessed a performance change of -9.23% over the past 12 months, the stock traded at a market price of $0.075.

ANTISENSE THERAPEUTICS LIMITED (ASX:ANP) – Despite any big news the company today resumed a big run that’s continued for two weeks. The stock spiked up to 9.4 c which was up by 450 percent two weeks ago. The stock was up 30 percent today and reached an intraday high of 5.1 c. For a treatment for Duchenne Muscular Dystrophy, the company has been focusing on Phase 2 clinical trial which is a muscle-wasting disease that affects boys only cutting lives short in their 20s and making them handicaps. Leaving $3.5 million in the bag, the company revealed a quarterly cash-burn rate of $835,000. The market capitalization of the company is $14.49 million which keeps Musgrave in small cap segment. The stock has witnessed a performance change of 23.077% as at October 29, 2018.

PROTEAN ENERGY LIMITED (ASX:POW) – The stock of Protean Energy surged up by 13.043% to trade at $0.026 as at October 29, 2018. The company has achieved significant milestones in advancing its uranium project in South Korea and the world class vanadium project through its 50% holding in South Korea by Stonehenge. No dividends have been declared, provided for or paid in respect of the financial year or period ending 30 June 2017. The Group made a net loss after tax of $3,669,481 for the financial year ended 30 June 2018 as compared to the 30 June 2017 with a loss of $7,107,731. At 30 June 2018, the Group had net assets of $6,969,874 compared to 30 June 2017 of $2,915,748 and cash assets of $2,419,879 compared to 30 June 2017 of $167,216.

Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.